Table 5.
Comparison of demographic and laboratory results between survival and non survival group (n = 88)
| Survived (n = 79) | Died (n = 9) | P value | |
| Age (yr) | 43 ± 15.7 | 39 ± 12.2 | 0.460a |
| Sex | |||
| Male, n (%) | 34 (43) | 2 (22.2) | 0.299c |
| Female, n (%) | 45 (57) | 7 (77.8) | |
| Duration at arrival (d) | 3.4 ± 3.9 | 2.9 ± 0.8 | 0.536b |
| Duration of hospital stay (d) | 12.9 ± 7.2 | 8.8 ± 11.4 | 0.012b |
| Hemoglobin (g/dL) | 9.6 ± 2.7 | 8.9 ± 2.4 | 0.435a |
| WBC count (× 103/mm3) | 14.5 ± 7.3 | 19.7 ± 7.5 | 0.023b |
| Platelets (× 103/mm3) | 119 ± 57 | 95 ± 67 | 0.218 |
| Urea (mg/dL) | 167 ± 78 | 186 ± 43 | 0.466 |
| Creatinine (mg/dL) | 7 ± 4.1 | 7 ± 2 | 0.997 |
| Sodium (mEq/L) | 135 ± 8 | 138 ± 4.6 | 0.182 |
| Potassium (mEq/L) | 4.8 ± 0.8 | 5.1 ± 1.2 | 0.392 |
| Albumin (g/dL) | 3.3 ± 0.4 | 3 ± 0.3 | 0.005 |
| Bilirubin (mg/dL) | 1.2 ± 1.1 | 3.1 ± 2.2 | 0.006b |
| AST (U/L) | 141 ± 283 | 254 ± 398 | 0.231b |
| ALT (U/L) | 101 ± 158 | 156 ± 200 | 0.102b |
| ALP (U/L) | 90 ± 67 | 122 ± 54 | 0.057b |
| CK (U/L) | 1811 ± 3762 | 4069 ± 7181 | 0.298b |
| LDH (U/L) | 1106 ± 1027 | 1684 ± 732 | 0.052b |
a
Independent samples t-test, sig. (2-tailed);
b
Mann-Whitney U test, Sig. (2-tailed), non parametric independent samples test;
c
χ2 with Fisher’s Extact test Exact sig. (2-sided). ALP: Alkaline phosphatase; AST: Aspartate aminotransferase; ALT: Alanine aminotransferase; CK: Creatine kinase; LDH: Lactate dehydrogenase.